pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Vera Therapeutics, Inc. ($VERA) · news · pharmadog
← back to Vera Therapeutics, Inc.
News mentioning $VERA
74
stories
1d
5 acquisitions that forced Big Pharmas to co-parent
biospace
2d
Vertex on the verge of ‘iconic’ evolution as key kidney disease verdict looms
biospace
10d
AI chatbots aren’t therapists. But can they finally get men to open up?
stat
13d
Verdicts for Summit/Akeso, Capricor, Vertex mark FDA’s stacked November
biospace
14d
Alethio raises $90M to target rare blood cancers
biopharma dive
Oct 19, 26
Merck KGaA makes noise in hematology with $1.1B Silence buy
biospace
Oct 19, 26
Merck KGaA bets on RNAi with $1.3B Silence buyout
biopharma dive
Oct 19, 26
Disc’s rebuffed rare disease drug sets up FDA redo after ‘clean’ Phase 3 sweep
biospace
Oct 19, 26
Disc’s rebuffed rare blood disease drug sets up FDA re-do after ‘clean’ Phase 3 sweep
biospace
Oct 19, 26
Merck KGaA buys Silence in $1.3B deal after siRNA drug's phase 2 blood cancer win
fiercebiotech
Sep 23, 26
Roche, Ionis RNA drug scores in kidney disease study
biopharma dive
Sep 23, 26
Roche kidney drug's Phase 3 win sets up path to accelerated approval
endpoints
Sep 17, 26
STAT+: New startup to test psychedelic-like drug against Parkinson’s symptom
stat
Sep 16, 26
STAT+: Sen. Warren demands to see Trump drug-pricing pharma contracts, accuses RFK Jr. of hiding them
stat
Sep 16, 26
U.S. reaches highest number of measles deaths in decades
stat
Sep 16, 26
5 biotechs braving the commercial waters with product launches
biospace
Sep 15, 26
STAT+: Obesity drugmakers are testing in kids as young as 6
stat
Sep 15, 26
Vera eyes full approval for Trutakna in IgAN following positive readout
endpoints
Sep 15, 26
STAT+: Vera kidney drug Trutakna shows strong final results in Phase 3 trial
stat
Sep 11, 26
Disc sets up polycythemia vera challenge but Silence maintains lead
biospace
Sep 10, 26
Takeda’s long-term R&D head announces exit after major pipeline reorganization
biospace
Aug 31, 26
FDA OKs Takeda, Protagonist drug for rare blood cancer
biopharma dive
Aug 31, 26
STAT+: We’re reading about drug pricing deals, a new cancer therapy approval, and more
stat
Aug 31, 26
Takeda, Protagonist score broad FDA nod in rare blood cancer, setting up $2B opportunity
biospace
Aug 30, 26
STAT+: FDA approves Protagonist and Takeda’s drug for rare blood cancer
stat
Aug 28, 26
FDA approves Takeda, Protagonist drug for rare blood disorder
endpoints
Aug 28, 26
FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder
fda press
Aug 17, 26
Vera’s newly approved IgA nephropathy drug supports kidney function, like Otsuka’s Voyxact
biospace
Aug 14, 26
Capricor shares spike on CEO comments; Cytokinetics sues Bristol Myers
biopharma dive
Aug 13, 26
Zealand sells milestone, royalty rights to rare blood cancer asset for up to $100M
biospace
← prev
page 1 of 3
next →